4/A: Koru Medical Systems Director Amends SEC Filing to Correct Shareholding

A Koru Medical Systems director amended a previous SEC filing to correct the number of shares beneficially owned following a recent transaction.

Summary

• Robert Cascella, a director at Koru Medical Systems, filed an amended Form 4 with the SEC.
• The amendment corrects a typographical error in the original filing regarding the number of shares beneficially owned after a transaction on July 11, 2024.
• The corrected number of shares beneficially owned is 65,165, down from the previously reported 65,524.
• The transaction on July 11, 2024, involved the acquisition of 5,545 common stock at a price of $2.71 per share.

Sentiment

Score: 7

Explanation: The document is a routine correction of a filing, indicating no significant positive or negative sentiment. The correction is a standard procedure and does not suggest any underlying issues.

Industry Context

This filing is a routine disclosure of insider transactions and is typical for publicly traded companies. It does not indicate any specific trend or event within the medical device industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this amendment is not unusual.
• The correction of a typographical error is not uncommon in these filings.
• The transaction itself is a relatively small acquisition of shares by a director, which is a common occurrence.

Stakeholder Impact

• The correction of the filing ensures accurate information is available to shareholders and the public.

Key Dates

Keywords

SEC Filing, Form 4, Beneficial Ownership, Koru Medical Systems, Director, Shareholding, Amendment